Can we predict the response to therapy in soft tissue sarcoma?

Future Oncol. 2018 Jan;14(2):101-104. doi: 10.2217/fon-2017-0497. Epub 2017 Dec 8.

Authors

Danielle File¹, Juneko E Grilley-Olson^{1

2}

Affiliations

¹ Department of Medicine, University of North Carolina, Chapel Hill, NC 27599, USA.
² Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC 27599, USA.

PMID: 29219624
DOI: 10.2217/fon-2017-0497

No abstract available

Keywords: neoadjuvant; pathologic response assessment; percent viable tumor; preoperative therapy; sarcoma.

Publication types

Editorial

MeSH terms

Disease-Free Survival
Humans
Neoadjuvant Therapy*
Sarcoma / drug therapy*
Sarcoma / epidemiology*
Sarcoma / pathology